HNGE Hinge Health, Inc.
Company Analysis
Latest News
🔴 Hinge Health is trading 4.3% down today in a post-earnings reversal despite raised guidance
Hinge Health is trading 4.3% down at $76.03 following a post-earnings reversal, despite reporting strong Q2 results and raising its full-year guidance. • The...
Hinge Health's second quarter revenue grew 53% to beat estimates, leading to raised FY2026 guidance and an acquisition.
Hinge Health reported second quarter 2026 revenue of $212.8 million, up 53% year-over-year, and GAAP EPS of $0.52, beating analyst estimates. The company also...
🟢 Hinge Health is trading 4.2% up today ahead of Q2 earnings and a broader risk-on rally
Hinge Health is trading 4.2% up at $80.91 as investors position ahead of its Q2 2026 earnings report and a broader risk-on market rally. • The company is...
🟢 Hinge Health is trading 4.6% up today ahead of Q2 earnings and broader market gains
Hinge Health is trading 4.6% up at $78.11 as investors position ahead of its Q2 2026 earnings report scheduled for August 4, 2026. • Analysts expect the...
Hinge Health, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Hinge Health, Inc. (HNGE) is projected to report Q2 2026 revenue of $201.1 million and EPS of $0.28, with shares currently trading near $74.71 compared to an...
🔴 Hinge Health is trading 4.1% down today amid profit-taking after a sharp multi-week rally
Hinge Health is trading at $72.02 (4.1% down) as the stock undergoes short-term consolidation and profit-taking following a sharp multi-week run. • The recent...
🔴 Hinge Health is trading 5.6% down
Hinge Health is trading at $79.66, down 5.6% from a comparison close of $84.35 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 Hinge Health is trading 4.03% down today despite broader market gains
Hinge Health is trading 4.03% down at $84.17 following a quiet session with no clearly identified company-specific catalyst. • The decline appears...
Hinge Health target raised to $108, Morgan Stanley cites improved growth outlook
Morgan Stanley raised its price target for Hinge Health (NYSE:HNGE) to $108 from $72. This adjustment represents a 50% increase while the bank maintains an...
Hinge Health Shareholder Insight Holdings Sells $38M Stake After Stock Conversion
Insight Holdings Group, LLC entities sold 426,171 shares of Hinge Health, Inc. Class A Common Stock on July 7 and July 9, 2026. The total transaction value...
🟢 HNGE is trading 4.1% up today as raised 2026 guidance and Russell index inclusion extend rally
HNGE is trading 4.1% up now at $86.42 as investors continue to react to Hinge Health’s recently raised second-quarter and full-year 2026 guidance. • Momentum...
Hinge Health Joins Russell Indexes, Boosting Investor Visibility and Liquidity
Hinge Health, Inc. will join the Russell 3000E and Russell 2000 Growth Indexes on June 29, 2026. The inclusion occurs as part of the annual Russell U.S....
🟢 HNGE extends move to 5.0% up
HNGE is trading at $82.94, up 5.0% versus the comparison close of $78.97 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 HNGE is trading 4.1% up today as rally extends on raised guidance and analyst revisions
HNGE is trading 4.1% up now at $82.21 as the stock extends a multi-day rally following its raised 2026 earnings guidance and upbeat analyst revisions. • The...
🟢 HNGE extends move to 5.1% up
HNGE is trading at $79.00, up 5.1% versus the comparison close of $75.14 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Hinge Health, Inc. is trading 4.27% up
HNGE is trading at $78.35, up 4.27%.
🟢 HNGE extends move to 5.1% up
HNGE is trading at $74.16, up 5.1% versus the comparison close of $70.56 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 HNGE is trading 4% up today after raising revenue guidance and analyst support
HNGE is trading 4% up at $73.39 after the company raised its Q2 and full-year 2026 revenue guidance and analysts reiterated their bullish outlook. • Analysts...
🟢 HNGE is trading 4.9% up today as company raises guidance and analysts maintain bullish outlook
HNGE is trading at $74.00 (+4.88%) in pre-market. The company recently raised its Q2 2026 revenue guidance to $200M-$202M and full-year 2026 guidance to...
🟢 Hinge Health, Inc. is trading 4.2% up today after Canaccord raises price target
Hinge Health, Inc. is trading 4.16% up at $68.06 following a strong open, driven by an analyst price target raise and a broad market rally. • Canaccord analyst...